Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/34832
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Koca, Süleyman Serdar | - |
dc.contributor.author | Öz, Burak | - |
dc.contributor.author | Karataş, Ahmet | - |
dc.contributor.author | Can, Gercek | - |
dc.contributor.author | Şenel, Soner | - |
dc.contributor.author | Yazıcı, Ayten | - |
dc.contributor.author | İnanç, Nevsun | - |
dc.contributor.author | Cefle, Ayşe | - |
dc.contributor.author | Ertürk, Zeynep | - |
dc.contributor.author | Akar, Servet | - |
dc.contributor.author | Göker, Berna | - |
dc.contributor.author | Birlik, Merih | - |
dc.contributor.author | Önen, Fatoş | - |
dc.date.accessioned | 2023-11-10T07:06:17Z | - |
dc.date.available | 2023-11-10T07:06:17Z | - |
dc.date.issued | 2018-06 | - |
dc.identifier.citation | Koca, S. S. vd. (2018). ''Concomitant use of corticosteroids at the baseline does not affect the drug survival of abatacept in rheumatoid arthritis''. Annals of the Rheumatic Diseases, 77(Supplement 2), 597-597. | en_US |
dc.identifier.issn | 0003-4967 | - |
dc.identifier.issn | 1468-2060 | - |
dc.identifier.uri | https://doi.org/10.1136/annrheumdis-2018-eular.5819 | - |
dc.identifier.uri | https://ard.bmj.com/content/77/Suppl_2/597.1 | - |
dc.identifier.uri | http://hdl.handle.net/11452/34832 | - |
dc.description | Bu çalışma, 13-16, Haziran 2018 tarihlerinde Amsterdam[Hollanda]’da düzenlenen Congress of the European-League-Against-Rheumatism (EULAR) Kongresi‘nde bildiri olarak sunulmuştur. | tr_TR |
dc.description.sponsorship | European League Against Rheumatism | en_US |
dc.language.iso | en | en_US |
dc.publisher | BMJ | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.rights | Atıf Gayri Ticari Türetilemez 4.0 Uluslararası | tr_TR |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Rheumatology | en_US |
dc.title | Concomitant use of corticosteroids at the baseline does not affect the drug survival of abatacept in rheumatoid arthritis | en_US |
dc.type | Meeting Abstract | en_US |
dc.identifier.wos | 000444351001568 | tr_TR |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Dahiliye Anabilim Dalı/Romatoloji Bilim Dalı. | tr_TR |
dc.identifier.startpage | 597 | tr_TR |
dc.identifier.endpage | 597 | tr_TR |
dc.identifier.volume | 77 | tr_TR |
dc.identifier.issue | Supplement 2 | en_US |
dc.relation.journal | Annals of the Rheumatic Diseases | en_US |
dc.contributor.buuauthor | Dalkılıç, Ediz | - |
dc.contributor.buuauthor | Pehlivan, Yavuz | - |
dc.contributor.buuauthor | Yağız, Burcu | - |
dc.contributor.researcherid | AAG-8227-2021 | tr_TR |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.subject.wos | Rheumatology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.wos | CPCIS | en_US |
dc.wos.quartile | Q1 | en_US |
Appears in Collections: | Web of Science |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Dalkılıç_vd_2018.pdf | 743.46 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License